| Pueblo Norte Senior Living Community | |
| 7100 East Mescal Street, Scottsdale, Arizona 85254 | |
| (480) 948-5800 | |
| Name | Pueblo Norte Senior Living Community |
|---|---|
| Location | 7100 East Mescal Street, Scottsdale, Arizona |
| Certified By | Medicare |
| No. of Certified Beds | 92 |
| Occupancy Rate | 54.24% |
| Medicare ID (CCN) | 035090 |
| Legal Business Name | Snh Az Tenant Llc |
| Ownership Type | For Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The Medical Research Council (MRC) has launched a Call for Proposals in experimental medicine today as part of its £15 million commitment to promote the translation of laboratory research into clinical practice for the benefit of patients.
Scientists have discovered an enzyme used in nature to make powerful chemicals from catnip to a cancer drug, vinblastine. The discovery opens up the prospect of producing these chemicals cheaply and efficiently.
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Pfizer and Keas announced today they have entered into an alliance to collaborate on the Keas platform to enable Health and Wellness experts to author, sell and distribute personalized online Care Plans directly to patients.
The U.S. Food and Drug Administration today approved Caldolor, the first injectable dosage form of the common pain medication ibuprofen, to treat pain and fever.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.51 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 57.63 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.77 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.61 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.96 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.3 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.81 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.17 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 17.93 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 5.6 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.92 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.14 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 70.92 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.76 | 82.93 |
News Archive
The Medical Research Council (MRC) has launched a Call for Proposals in experimental medicine today as part of its £15 million commitment to promote the translation of laboratory research into clinical practice for the benefit of patients.
Scientists have discovered an enzyme used in nature to make powerful chemicals from catnip to a cancer drug, vinblastine. The discovery opens up the prospect of producing these chemicals cheaply and efficiently.
Building on research published eight years ago in the journal Chemistry and Biology, Kenneth S. Kosik, Harriman Professor in Neuroscience and co-director of the Neuroscience Research Institute (NRI) at UC Santa Barbara, and his team have now applied their findings to two distinct, well-known mouse models, demonstrating a new potential target in the fight against Alzheimer's and other neurodegenerative diseases.
Pfizer and Keas announced today they have entered into an alliance to collaborate on the Keas platform to enable Health and Wellness experts to author, sell and distribute personalized online Care Plans directly to patients.
The U.S. Food and Drug Administration today approved Caldolor, the first injectable dosage form of the common pain medication ibuprofen, to treat pain and fever.
› Verified 4 days ago
Haven Of Scottsdale Location: 3293 North Drinkwater Boulevard, Scottsdale, Arizona 85251 Phone: (480) 947-7443 | |
Osborn Health And Rehabilitation Location: 3333 North Civic Center Plaza, Scottsdale, Arizona 85251 Phone: (480) 994-1333 | |
Heritage Court Post Acute Of Scottsdale Location: 3339 North Drinkwater Boulevard, Scottsdale, Arizona 85251 Phone: (480) 949-5400 | |
Plaza Healthcare Location: 1475 North Granite Reef Road, Scottsdale, Arizona 85257 Phone: (480) 990-1904 | |
Pueblo Norte Senior Living Community Location: 7100 East Mescal Street, Scottsdale, Arizona 85254 Phone: (480) 948-5800 | |
Shea Post Acute Rehabilitation Center Location: 11150 North 92nd Street, Scottsdale, Arizona 85260 Phone: (480) 860-1766 |